National Comprehensive Cancer Network

NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN Drug and Biologics Compendium - Panel Members

Professionals


Go back to previous page

 

 

   
 

NCCN Drugs & Biologics Compendium

NCCN Non-Hodgkin's Lymphoma Panel Members

These chapters of the NCCN Drugs & Biologics Compendium™ were developed directly from the NCCN Clinical Practice Guidelines in Oncology for Non-Hodgkin's Lymphoma.

These guidelines were developed by the following NCCN Non-Hodgkin's Lymphoma Panel Members.

Andrew D. Zelenetz, MD, PhD/Chair
Memorial Sloan-Kettering Cancer Center
Non-Hodgkin's Lymphoma

Jeremy S. Abramson, MD
Massachusetts General Hospital Cancer Center
Non-Hodgkin's Lymphoma

Ranjana H. Advani, MD
Stanford Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

C. Babis Andreadis, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Nancy Bartlett, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Non-Hodgkin's Lymphoma

John C. Byrd, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
Non-Hodgkin's Lymphoma

Myron S. Czuczman, MD
Roswell Park Cancer Institute
Non-Hodgkin's Lymphoma

Luis Fayad, MD
The University of Texas MD Anderson Cancer Center
Non-Hodgkin's Lymphoma

Andres Forero, MD
University of Alabama at Birmingham Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Martha J. Glenn, MD
Huntsman Cancer Institute at the University of Utah
Non-Hodgkin's Lymphoma

Jon P. Gockerman, MD
Duke Cancer Institute
Non-Hodgkin's Lymphoma

Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Non-Hodgkin's Lymphoma

Nancy Lee Harris, MD
Massachusetts General Hospital Cancer Center
Non-Hodgkin's Lymphoma

Richard T. Hoppe, MD
Stanford Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center
Non-Hodgkin's Lymphoma

Christopher R. Kelsey, MD
Duke Cancer Institute
Non-Hodgkin's Lymphoma

Youn H. Kim, MD
Stanford Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Ann S. LaCasce, MD
Dana-Farber/Brigham and Women's Cancer Center
Non-Hodgkin's Lymphoma

Auyporn Nademanee, MD
City of Hope Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Pierluigi Porcu, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
Non-Hodgkin's Lymphoma

Oliver Press, MD, PhD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Non-Hodgkin's Lymphoma

Leonard Prosnitz, MD
Duke Cancer Institute
Non-Hodgkin's Lymphoma

Nishitha Reddy, MD
Vanderbilt-Ingram Cancer Center
Non-Hodgkin's Lymphoma

Lubomir Sokol, MD, PhD
H. Lee Moffitt Cancer Center & Research Institute
Non-Hodgkin's Lymphoma

Lode Swinnen, MB, ChB
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Non-Hodgkin's Lymphoma

Christina Tsien, MD
University of Michigan Comprehensive Cancer Center
Non-Hodgkin's Lymphoma

Julie M. Vose, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center
Non-Hodgkin's Lymphoma

William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center
Non-Hodgkin's Lymphoma

Joachim Yahalom, MD
Memorial Sloan-Kettering Cancer Center
Non-Hodgkin's Lymphoma

Nadeem Zafar, MD
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute
Non-Hodgkin's Lymphoma

Disclosures for the NCCN Non-Hodgkin's Lymphoma Guidelines Panel